IMRN

Immuron Ltd

• TipRanks·08/13 10:29

  Immuron CEO to Present Company’s Gut Health Pipeline at Emerging Growth Conference

• TipRanks·07/21 10:33

  Immuron CEO to Present TechKnow Invest Roadshow in Melbourne

• TipRanks·07/20 12:27

  Immuron Showcases Oral Antibody Platform in July 20 Investor Presentation

• Benzinga·07/16 10:25

  Immuron Sees Prelim FY2026 Sales $5.462M

• Benzinga·07/06 10:05

  Immuron Hires Pullan To Find Partner For Gut Infection Drug, Seeks Strategic Partner For FDA-Cleared IMM-529 Trial

• TipRanks·06/23 10:30

  Immuron Completes Buy-Back of Unmarketable Parcels to Streamline Share Register

• Benzinga·05/27 21:05

  12 Health Care Stocks Moving In Wednesday's After-Market Session

• TipRanks·05/08 10:34

  Immuron Showcases Oral Antibody Portfolio at Emerging Growth Conference

• Seeking Alpha·04/17 11:34

  Immuron Q3 sales rise 16% to A$1.5M

• Benzinga·04/10 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• Benzinga·02/25 13:26

  Immuron H1 EPS $(0.01), Same YoY, Sales $4.184M Up From $3.994M YoY

• Seeking Alpha·02/25 11:14

  Immuron reports 1H results

• TipRanks·01/20 12:27

  Immuron Reports Continued Travelan Sales Growth and ProIBS Launch in H1 FY26

• Benzinga·01/20 08:29

  Reported Monday, Immuron Reports Continued Sales Growth With H1 Global Sales Of AUD$4.2M, Up 5%, Driven By Travelan And ProIBS Launch

• Benzinga·12/16/2025 10:53

  Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket